The independent source for health policy research, polling, and news.
31,241 - 31,260 of 112,390 Results
A recent study has found just how dangerous pollution is to the world's health. In other public health news: high blood pressure, obesity and cholesterol, tobacco, adult-onset ADHD, broken hearts and concussions.
“Some [increases] exceeded inflation drastically and some increased at a slower rate,” said Dr. Daniel Goldstein, the author of the study. “But overall, we’re seeing a gradual creep each year.”
The Kaiser Family Foundation's annual survey of 50 states looks at changes expected in Medicaid programs. In other Medicaid news, Pennsylvania's governor vetoes a bill that would impose work requirements for enrollees, Louisiana lawmakers weigh new contracts for managed care companies and New Hampshire approves coverage of gender reassignment surgeries.
Also in the news from the Centers for Medicare & Medicaid Services, the agency will begin evaluating some of the changes put in place by MACRA to reduce Medicare spending.
The court did, however, allow for the girl to see a counselor -- which Texas law requires before obtaining an abortion. If the stay is lifted, she could decide to seek the procedure later today or tomorrow.
“President Trump wants to make birth control about ideology, but let’s be clear: for women and their families in the 21st century, birth control is about being healthy and financially secure,” said Sen. Patty Murray (D-Wash.).
As uncertainty reigns in Washington, D.C., insurers are more focused on the rest of America and making sure people know what to do when enrollment kicks off. In other marketplace news: middle-class Americans are upset about insurer subsidies being cut off; a look at the way this enrollment season will be different; uninsured numbers are expected to rise; and more.
“They are not ready for this,” a public health advocate said of an emergency declaration after talking to Health and Human Services officials enlisted in the effort. Meanwhile, states have been quietly taking matters into their own hands.
Many of the changes President Donald Trump wants to see in the legislation are ones that couldn't get through Congress this summer.
Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) have an unusually high number of sponsors on their legislation -- 12 lawmakers from each party -- and Sen. Chuck Schumer (D-N.Y.) promises that every Democrat will vote for it, meaning it seems to have the 60 votes necessary to overcome a fillibuster.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
These private insurance plan take the place of traditional Medicare and vary in coverage and cost.
Opinion writers offer a variety of takes on the deal announced this week by Sen. Lamar Alexander (R-Tenn.) and Sen. Patty Murray (D-Wash.) as well as what it can and cannot accomplish. They also take a tough inventory of the politics in play and examine other health policy issues, such as Medicare Advantage networks and the status of the Children's Health Insurance Program reauthorization.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from Maryland, New York, Colorado, Illinois, Pennsylvania, Ohio and Minnesota.
Proponents have said eating placenta reduces pain, improves mood and energy level, increases milk production, but scientists find any evidence to support those claims lacking. In other public health news: diabetes during pregnancy, other viruses to look out for this flu season, concussions in teenagers, infectious diseases, and postpartum depression.
Rep. Tom Marino (R-Pa.) withdrew his name from consideration after reports tying him to legislation that undermined the Drug Enforcement Administration's power during the opioid crisis.
The therapy is part of a hot new field that uses a patient's own immune system to turn the cells into a "living drug" that attacks disease.
The new business, which will start in 2020, will be a new pharmacy benefit manager (PBM) company. PBMs serve as intermediaries between drug companies and the prescription plans, but they have come under increasing pressure for not being transparent about how much money they save and how much is passed along to consumers.
© 2026 KFF